Skip to content

Research on treatments for pain using MSC-CM

Research on Treatments for pain Using Human-Derived Mesenchymal Stem Cell Conditioned Medium

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1051260066
Enrollment
30
Registered
2026-06-02
Start date
2026-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain pain

Interventions

None listed

Sponsors

Sugawara Yu
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Individuals who did not experience satisfactory treatment effects with standard therapy. 2. Individuals who do not wish to undergo treatment with drugs commonly used in standard therapy due to concerns about side effects, and whose physicians have determined that treatment with conditioned medium is appropriate. Inclusion criteria for patients are as follows: Patients meeting the following criteria are eligible: 1. Individuals aged 18 years or older. 2. Individuals with normal capacity to consent. 3. Individuals who have been provided with the informed consent document for this treatment, have received sufficient explanation, and are capable of providing written consent freely and voluntarily. 4. Individuals for whom the attending physician has recognized the necessity of treatment.

Exclusion criteria

Exclusion criteria: Individuals who meet any of the following conditions will be excluded: 1. Individuals who use narcotics or stimulants. 2. Individuals deemed inappropriate by the attending physician.

Design outcomes

Primary

MeasureTime frame
The following items will be assessed regarding the subjective symptoms of study participants: 1. Impact of pain on daily life 2. Pain pattern 3. Pain intensity (Numerical Rating Scale; NRS) 4. Pain location 5. Pain characteristics

Contacts

Public ContactYu Sugawara

Jingu Gaien Woman Life Clinic

sugasmileu@gmail.com+81-3-6432-9385

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026